Catalyst's management team will host a conference call and webcast on Thursday, February 26, at 8:30 AM ET to discuss the Company's financial results and provide a business update.
Catalyst Pharmaceuticals, Inc. is upgraded to Hold as FIRDAPSE's loss-of-exclusivity risk is deferred to 2035, stabilizing its revenue base. CPRX's AGAMREE launch outpaces expectations, with 115% Y/Y ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results